JHS Svendgaard: Deviation in Fund Utilization for Q2 FY27

JHS Svendgaard Laboratories Ltd has filed a Statement of Deviation and Variation for the quarter ended September 30, 2026, as per SEBI regulations. The company raised Rs. 29.99 crores via Preferential Issue on June 4, 2024. There is a deviation in the utilization of funds raised, which is pursuant to a change in terms approved by shareholders on July 29, 2026. Key areas with deviations include capital expenditure for acquiring equipment and business expansion, and infusion of funds in a group entity for strategic growth initiatives. The general corporate purpose allocation remained unchanged.